Protein ANKRD5: Potential Drug Target for Brain Disorders (G283373)

Target Name: ANKRD52

NCBI ID: G283373

ANKRD52

Protein ANKRD5: Potential Drug Target for Brain Disorders

ANKRD52 (CVWG5837) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a member of the ANKRD5 gene family, which is known for its role in cell signaling and metabolism.

The ANKRD5 gene was identified as a potential drug target due to its involvement in a variety of cellular processes that are important for brain development and function. One of the key functions of ANKRD5 is its role in the regulation of cellular signaling pathways, including those that involve neurotransmitter release and synaptic plasticity.

ACKRD5 has been shown to play a role in the regulation of neurotransmitter release from neurons, which is important for the transmission of signals in the brain. Studies have shown that ANKRD5 is involved in the regulation of the release of dopamine, serotonin, and other neurotransmitters, which are involved in a variety of brain functions, including mood regulation, learning, and memory.

In addition to its role in neurotransmitter release, ANKRD5 has also been shown to be involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Synaptic plasticity is important for the development and maintenance of neural circuits, and is thought to play a key role in the treatment of neurological and psychiatric disorders.

The ANKRD5 gene is also involved in the regulation of cellular metabolism, which is important for the survival and growth of cells. Studies have shown that ANKRD5 is involved in the regulation of cellular metabolism, including the metabolism of glucose and lipids.

In conclusion, ANKRD5 is a protein that is involved in a variety of cellular processes that are important for brain development and function. As a potential drug target, ANKRD5 is a promising target for the development of new treatments for a variety of neurological and psychiatric disorders. Further research is needed to fully understand the role of ANKRD5 in cellular processes and its potential as a drug target.

Protein Name: Ankyrin Repeat Domain 52

Functions: Putative regulatory subunit of protein phosphatase 6 (PP6) that may be involved in the recognition of phosphoprotein substrates

The "ANKRD52 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD52 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets